David Jin
2022 - Fortress Biotech
In 2022, David Jin earned a total compensation of $1.5M as Chief Financial Officer and Head of Corporate Development at Fortress Biotech.
Compensation breakdown
Bonus | $52,500 |
---|---|
Salary | $338,500 |
Stock Awards | $1,123,281 |
Other | $33,882 |
Total | $1,548,163 |
Jin received $1.1M in stock awards, accounting for 73% of the total pay in 2022.
Jin also received $52.5K in bonus, $338.5K in salary and $33.9K in other compensation.
Rankings
In 2022, David Jin's compensation ranked 2,157th out of 5,676 executives tracked by ExecPay. In other words, Jin earned more than 62.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,157 | 62nd |
Manufacturing | 1,160 | 62nd |
Chemicals And Allied Products | 498 | 64th |
Drugs | 458 | 65th |
Pharmaceutical Preparations | 331 | 65th |
Jin's colleagues
We found two more compensation records of executives who worked with David Jin at Fortress Biotech in 2022.
News
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2023 pay stays at $350K
August 28, 2024
AVENUE THERAPEUTICS CEO Alexandra MacLean's 2023 pay jumps 304% to $1.2M
May 3, 2024
Fortress Biotech CFO David Jin's 2023 pay jumps 267% to $1.3M
April 5, 2024
Avalon GloboCare Corp. CEO David Jin's 2022 pay stays at $360K
September 8, 2023
Avalon GloboCare Corp. CEO David Jin's 2021 pay falls 64% to $360K
November 21, 2022
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2020 pay slips 20% to $1.1M
December 13, 2021
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2019 pay rises 3% to $1.3M
June 22, 2020
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2018 pay jumps 34% to $1.3M
June 17, 2019